David Lawrence
2008
In 2008, David Lawrence earned a total compensation of $1M as Chief Financial Officer at Acorda Therapeutics, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $82,067 |
|---|---|
| Option Awards | $416,683 |
| Salary | $252,400 |
| Stock Awards | $245,644 |
| Other | $6,900 |
| Total | $1,003,694 |
Lawrence received $416.7K in option awards, accounting for 42% of the total pay in 2008.
Lawrence also received $82.1K in bonus, $252.4K in salary, $245.6K in stock awards and $6.9K in other compensation.
Rankings
In 2008, David Lawrence's compensation ranked 4,394th out of 9,135 executives tracked by ExecPay. In other words, Lawrence earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,394 out of 9,135 | 52nd |
Division Manufacturing | 1,573 out of 3,436 | 54th |
Major group Chemicals And Allied Products | 301 out of 815 | 63rd |
Industry group Drugs | 179 out of 597 | 70th |
Industry Biological Products, Except Diagnostic Substances | 35 out of 118 | 70th |
Source: SEC filing on April 29, 2011.
Lawrence's colleagues
We found three more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2008.